Role of Spevigo® (spesolimab-sbzo) Injection in the Treatment of Generalized Pustular Psoriasis

This article provides an overview of generalized pustular psoriasis (GPP) and its clinical and economic impact, and reviews findings of Effisayil^® 2, the first trial to study subcutaneous Spevigo^® (spesolimab-sbzo) in patients with GPP when not experiencing a flare.